Applied Clinical Trials-02-01-2014

CRO/Sponsor: Integrating Managed Access Programs: Global Considerations Trial Design: How to Improve Clinical Research in Children Also in this issue: Global Experience with Informed Consent Central Statistical Monitoring Sponsor/CRO Interaction

A survey on the perception of European pediatricians and industry/CROs

A discussion of summary findings from the CISCRP 2013 Perceptions & Insights Study

MAPs can effectively address unmet patient needs and become a cornerstone of product strategy.

Pharma needs to find a balance in working with Sponsors and CROs in order to streamline the study processes.

IMS Health

The European Union has a new research program, but will it help, or hinder, clinical trials?

The decline in important new medicines reaching market in 2013 has produced multiple proposals for making clinical trials more effective and efficient.

S

Devoting time to work on "correctable weaknesses" of research design will pay off in the long run.

While capable of conducting high-quality trials, the current oversight process can be expensive and inefficient.